L
Lisa Rogers
Researcher at University Hospitals of Cleveland
Publications - 54
Citations - 1173
Lisa Rogers is an academic researcher from University Hospitals of Cleveland. The author has contributed to research in topics: Cancer & Glioma. The author has an hindex of 12, co-authored 48 publications receiving 1004 citations. Previous affiliations of Lisa Rogers include Case Western Reserve University.
Papers
More filters
Journal ArticleDOI
Cerebrovascular complications in patients with cancer.
TL;DR: Neuroimaging studies, measurement of coagulation function, and echocardiography are the must useful modalities to identify the cause of stroke.
Journal ArticleDOI
Central nervous system cancers, version 1.2017 featured updates to the NCCN guidelines
Louis B. Nabors,Jana Portnow,Mario Ammirati,Joachim Baehring,Henry Brem,Nicholas Butowski,Robert A. Fenstermaker,Peter A. Forsyth,Jona A. Hattangadi-Gluth,Matthias Holdhoff,Steven P. Howard,Larry Junck,Thomas Kaley,Priya Kumthekar,Jay S. Loeffler,Paul L. Moots,Maciej M. Mrugala,Seema Nagpal,Manjari Pandey,Ian F. Parney,Katherine B. Peters,Vinay K. Puduvalli,John Ragsdale,Jason K. Rockhill,Lisa Rogers,Chad G. Rusthoven,Nicole Shonka,Dennis C. Shrieve,Allen K. Sills,Lode J. Swinnen,Christina Tsien,Stephanie E. Weiss,Patrick Y. Wen,Nicole Willmarth,Mary Anne Bergman,Anita M. Engh +35 more
TL;DR: Analysis of molecular markers across populations from randomized clinical trials have shown that some of these markers are also predictive of response to specific types of treatment, which has prompted significant changes to the recommended treatment options for grade III gliomas.
Journal ArticleDOI
Computer-Extracted Texture Features to Distinguish Cerebral Radionecrosis from Recurrent Brain Tumors on Multiparametric MRI: A Feasibility Study.
Pallavi Tiwari,Prateek Prasanna,Leo J. Wolansky,Marco Da Cunha Pinho,Mark L. Cohen,Ameya Nayate,Anirban Sen Gupta,Gagandeep Singh,Kimmo J. Hatanpaa,Andrew E. Sloan,Lisa Rogers,Anant Madabhushi +11 more
TL;DR: The preliminary results suggest that radiomic features may provide complementary diagnostic information on routine MR imaging sequences that may improve the distinction of radiation necrosis from recurrence for both primary and metastatic brain tumors.
Journal ArticleDOI
Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010
Adah S. Zhang,Quinn T. Ostrom,Carol Kruchko,Lisa Rogers,David M. Peereboom,David M. Peereboom,Jill S. Barnholtz-Sloan +6 more
TL;DR: The relative impact of malignant primary brain tumors is higher among children than any other age group; it emerges as the second most prevalent cancer among children.
Journal ArticleDOI
Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
Mojgan Hojjati,Chaitra Badve,Vasant Garg,Curtis Tatsuoka,Lisa Rogers,Andrew E Sloan,Peter Faulhaber,Pablo R. Ros,Leo J. Wolansky +8 more
TL;DR: To compare the utility of quantitative PET/MRI, dynamic susceptibility contrast (DSC) perfusion MRI (pMRI), and PET/CT in differentiating radiation necrosis (RN) from tumor recurrence (TR) in patients with treated glioblastoma multiforme (GBM).